Olema Pharmaceuticals (OLMA) had the highest return last month by a mid-cap US stock, returning 214.7%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Olema Pharmaceuticals (OLMA) | November 2025 | 214.67% |
PACS (PACS) | November 2025 | 175.89% |
Cogent Biosciences (COGT) | November 2025 | 147.51% |
Cidara Therapeutics (CDTX) | November 2025 | 103.27% |
Terns Pharmaceuticals (TERN) | November 2025 | 100.07% |
Inspire Medical Systems (INSP) | November 2025 | 72.65% |
Haemonetics (HAE) | November 2025 | 63.03% |
McGraw Hill (MH) | November 2025 | 59.11% |
Kohl's (KSS) | November 2025 | 53.21% |
Nuvation Bio (NUVB) | November 2025 | 50.37% |
Scholar Rock (SRRK) | November 2025 | 49.91% |
Polibeli Group Ltd Class A Ordinary Shares (PLBL) | November 2025 | 47.82% |
Brinker International (EAT) | November 2025 | 43.29% |
Comstock Resources (CRK) | November 2025 | 42.87% |
Edgewise Therapeutics (EWTX) | November 2025 | 42.45% |
Aris Mining (ARMN) | November 2025 | 42.11% |
Progyny (PGNY) | November 2025 | 40.94% |
Seaboard (SEB) | November 2025 | 40.9% |
Callaway Golf (MODG) | November 2025 | 38.49% |
10X Genomics (TXG) | November 2025 | 37.6% |
Teradata (TDC) | November 2025 | 37.49% |
Compass (COMP) | November 2025 | 37.47% |
Abercrombie & Fitch (ANF) | November 2025 | 37.15% |
Orla Mining (ORLA) | November 2025 | 36.63% |
Viridian Therapeutics (VRDN) | November 2025 | 36% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
